Samuel Hernandez Named Site Head of TX Fujifilm Biotechnologies Facility

Fujifilm Biotechnologies appointed Samuel Hernandez, Ph.D., as senior vice president and site head for its College Station, Texas facility, effective Monday, August 25. The previous site head, Keita Hirabayashi, has been appointed to the position of senior director, Corporate Office, and board member of the Texas site.

With over two decades of experience in biotechnology and pharmaceutical leadership, Hernandez is positioned to lead the Texas team of about 770 in the continued growth of cell culture and advanced therapies offerings. 

In his new role, Hernandez will oversee Texas site strategy, operations, talent development, and uphold Fujifilm Biotechnologies’ commitment to quality, innovation, and reliable supply for its partners.

Hernandez joins the company from Amgen, where he recently served as executive director and head of Global Manufacturing Strategies and Technologies. In this role, he contributed to the strategy for manufacturing capacity expansion and integrated technologies across sites in the U.S., Puerto Rico, Europe, and Asia. 

His tenure as plant manager at Amgen’s Juncos, Puerto Rico, site was marked by operational transformation, including the introduction of new products and critical partnerships, notably manufacturing a COVID-19 neutralizing antibody therapy. 

“We are thrilled to have Sam join our team to lead our Texas site during an exciting period where we are supporting treatments to combat serious diseases such as cancers,” said Lars Petersen, president and chief executive officer, Fujifilm Biotechnologies. “His commitment to quality and our People First culture will enable us to continue our growth journey at this site.”